These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6849770)

  • 1. Effects of feeding on the systemic clearance of indocyanine green and propranolol blood concentrations and plasma binding.
    Feely J; Nadeau J; Wood AJ
    Br J Clin Pharmacol; 1983 Mar; 15(3):383-5. PubMed ID: 6849770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol.
    Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and nicotine metabolism.
    Lee BL; Jacob P; Jarvik ME; Benowitz NL
    Pharmacol Biochem Behav; 1989 Jul; 33(3):621-5. PubMed ID: 2587604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
    Wood AJ; Kornhauser DM; Wilkinson GR; Shand DG; Branch RA
    Clin Pharmacokinet; 1978; 3(6):478-87. PubMed ID: 719984
    [No Abstract]   [Full Text] [Related]  

  • 10. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
    Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
    Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet.
    Fagan TC; Walle T; Oexmann MJ; Walle UK; Bai SA; Gaffney TE
    Clin Pharmacol Ther; 1987 Apr; 41(4):402-6. PubMed ID: 3829577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent disposition of oral propranolol in normal subjects.
    Mackichan JJ; Pyszczynski DR; Jusko WJ
    Biopharm Drug Dispos; 1980; 1(4):159-66. PubMed ID: 7448344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".
    Weber C; Stoeckel K; Lalka D
    Pharm Res; 1994 Mar; 11(3):420-5. PubMed ID: 8008710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.